The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The burden of cancer in Japan, the United States, France, Germany, Italy, Spain, Sweden, and the United Kingdom.
N. Koinuma
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma
N. E. Wilking
Research Funding - Chugai Pharma
B. Jonsson
Research Funding - Chugai Pharma
D. Hogberg
Research Funding - Chugai Pharma